Xiyuan Luo
Overview
Explore the profile of Xiyuan Luo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang J, Zhou F, Luo X, Fang Y, Wang X, Liu X, et al.
Cell Death Discov
. 2025 Mar;
11(1):84.
PMID: 40032852
Transcriptional dysregulation is a hallmark of cancer initiation and progression, driven by genetic and epigenetic alterations. Enhancer reprogramming has emerged as a pivotal driver of carcinogenesis, with cancer cells often...
2.
Liu X, Wang X, Ren J, Fang Y, Gu M, Zhou F, et al.
BMC Cancer
. 2025 Jan;
25(1):6.
PMID: 39754071
Background: Pancreatic cancer is a highly aggressive neoplasm characterized by poor diagnosis. Amino acids play a prominent role in the occurrence and progression of pancreatic cancer as essential building blocks...
3.
Xie Y, Luo X, Di X, Li J, Xia Y, Wang L, et al.
Anal Chem
. 2024 Oct;
96(43):17154-17164.
PMID: 39418483
Real-time monitoring of chemotherapy-induced senescence (CIS) in cancer remains a challenging task that would lead to new insights into the adaptive mechanisms of cancer therapy and provide guidance for cancer...
4.
Wang X, Liu X, Xiao R, Fang Y, Zhou F, Gu M, et al.
Cancer Lett
. 2024 Jul;
598:217117.
PMID: 39019144
Cancer cells rewire metabolism to sculpt the immune tumor microenvironment (TME) and propel tumor advancement, which intricately tied to post-translational modifications. Histone lactylation has emerged as a novel player in...
5.
Liu X, Ren B, Fang Y, Ren J, Wang X, Gu M, et al.
J Transl Med
. 2024 Apr;
22(1):393.
PMID: 38685045
Background: Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with high probability of recurrence and distant metastasis. Liver metastasis is the predominant metastatic mode developed in most pancreatic cancer cases,...
6.
Gu M, Ren B, Fang Y, Ren J, Liu X, Wang X, et al.
MedComm (2020)
. 2024 Feb;
5(2):e495.
PMID: 38374872
Epigenetic modifications are defined as heritable changes in gene activity that do not involve changes in the underlying DNA sequence. The oncogenic process is driven by the accumulation of alterations...
7.
Li J, Wang L, Luo X, Xia Y, Xie Y, Liu Y, et al.
Anal Chem
. 2023 Feb;
95(8):3996-4004.
PMID: 36795559
Specific imaging of cellular senescence emerges as a promising strategy for early diagnosis and treatment of various age-related diseases. The currently available imaging probes are routinely designed by targeting a...
8.
Xie J, Luo X, Deng X, Tang Y, Tian W, Cheng H, et al.
Front Immunol
. 2023 Jan;
13:1076883.
PMID: 36685496
Tumor immunotherapy, particularly the use of immune checkpoint inhibitors, has yielded impressive clinical benefits. Therefore, it is critical to accurately screen individuals for immunotherapy sensitivity and forecast its efficacy. With...
9.
Xia Y, Li J, Wang L, Luo X, Xie Y, Liu Y
Angew Chem Int Ed Engl
. 2022 Jan;
61(12):e202115764.
PMID: 35037392
Specific intervention of senescent cells (SnCs) is emerging as a powerful means to counteract aging and age-related diseases. Canonical methods are generally designed to target SnC-associated signaling pathways, which are...